Eli Lilly, Novo Euphoria Risks Disappointing Investors, Goldman Says [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
(Bloomberg) -- The weight loss drug frenzy that's driven Eli Lilly & Co. and Novo Nordisk A/S to record peaks is raising the stakes for investors, according to Goldman Sachs Group Inc. analysts. Most Read from Bloomberg Israel Bracing for Unprecedented Direct Iran Attack in Days Apple Plans to Overhaul Entire Mac Line With AI-Focused M4 Chips Russian Attacks on Ukraine Stoke Fears Army Near Breaking Point Stocks Get Hit as War Jitters Fuel Rush to Bonds: Markets Wrap US Sees Imminent Missile Strike on Israel by Iran, Proxies “Expectations are high, which heightens the risk to potentially disappoint,” according to analyst Chris Shibutani, who said investors have been buying into the obesity drug demand narrative and pricing in “a significant amount of optimism.” Shibutani, who maintains a hold rating on Lilly, said if the drugmakers were unable to meet the surging demand for the drugs, that could dent the enthusiasm for the stocks. Supply shortages have dogged the popu
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q1 Earnings Report [Yahoo! Finance]Yahoo! Finance
- Here's How Much Stock Eli Lilly Repurchased in 2023 [Yahoo! Finance]Yahoo! Finance
- Sermonix Pharmaceuticals Announces ‘Menopause' Journal Publication of Article on Oral Lasofoxifene's Effects on Vaginal Atrophy in Postmenopausal Women [Yahoo! Finance]Yahoo! Finance
- Eli Lilly Just Announced More Good News: Time to Buy? [Yahoo! Finance]Yahoo! Finance
- Is Viking Therapeutics Incredibly Undervalued? [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 2/6/24 - Miss
LLY
Sec Filings
- 4/16/24 - Form 4
- 4/16/24 - Form 4
- 4/16/24 - Form 4
- LLY's page on the SEC website